Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer

Clinical trial NCT05712941 · WITHDRAWN

Trial details

NCT number: NCT05712941
Sponsor: EQRx International, Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Endometrial Carcinoma

Start date: 2023-04-18
Primary completion: 2024-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.